SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

Lexeo Therapeutics Price Target Maintained With a $15.00/Share by Leerink Partners

Ratings actions from Benzinga: GMT) Lexeo Therapeutics Is Maintained at Outperform by Leerink PartnersRatings actions from Benzinga

LXEO

Related stories